Q3 2026 Sumitomo Chemical Co Ltd Earnings Call Transcript
Key Points
- Core operating income and net income attributable to owners of the parent significantly increased compared to the same period of the previous fiscal year.
- Sumitomo Pharma's strong sales and partial divestiture of the Asian business recorded a gain, contributing to increased core operating income.
- Essential & Green Materials segment saw a significant year-on-year increase in core operating income due to gains from the partial sale of shares in Petro Rabigh and improved trade terms.
- Agro & Life Solutions segment experienced solid performance, with strong shipments in Japan and India.
- The company announced an increase in the year-end dividend per share, reflecting improved profit and loss outlook.
- Sales revenue decreased by JPY198.5 billion year-on-year, with declines in all segments except Sumitomo Pharma.
- Nonrecurring items resulted in a total loss of JPY6.4 billion, worsening by JPY91.8 billion compared to the previous year.
- Finance income recorded a loss of JPY36 billion, with a worsening of JPY22.8 billion year-on-year in foreign currency transactions.
- The ICT & Mobility Solutions segment saw a decline in core operating income due to decreased shipments of display-related materials.
- The company anticipates recording losses from nonrecurring items concentrated in the fourth quarter, impacting overall profitability.
As it is time to start, we will now begin the conference call for the presentation of financial results for fiscal year 2025 third quarter. Thank you very much for your participation.
Today, Mr. Yamauchi, Executive Officer and General Manager of Accounting Department, will give a briefing. And later, we will have a Q&A session. We will conclude the call at around 16:50.
Now Mr. Yamauchi, over to you.
Thank you very much. This is Yamauchi speaking. Thank you very much for attending the Sumitomo Chemical conference call despite your busy schedule. I'd like to thank investors and analysts for your deep understanding and support to our management. Thank you very much for that.
Now let me start with a briefing of the financial results for fiscal year 2025 third quarter. Before explaining the details of our financial results, I would like to give a brief update on the status of profit and loss for the third quarter. Core operating income and net
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
